GUCY2C and colorectal carcinoma: The study concluded that GCC could possibly be utilized as a highly specific identification biomarker for the successful detection of CRC in diagnostic applications, as well as serve as a precise targeting ligand for enhanced drug delivery in CRC treatments [31].